Justia U.S. Federal Circuit Court of Appeals Opinion Summaries

This case revolves around Mr. Orville Thomas, a former U.S. Navy serviceman, who sought an earlier effective date for his post-traumatic stress disorder (PTSD) claim connected to his service. Thomas had initially filed a claim for "depressive mania" in 1971, after surviving a plane crash during his service, which had been denied by the U.S. Department of Veterans Affairs (VA). In 2014, he requested to reopen his claim, submitting additional service department records not previously considered by the VA. While the VA granted service connection for PTSD in 2014, they denied an earlier effective date.Thomas appealed to the Board of Veterans’ Appeals, arguing the VA had overlooked certain service department records and regulations, specifically 38 C.F.R. § 3.156(c), which could have potentially allowed for an earlier effective date. However, the Board agreed with the VA’s denial. Thomas further appealed to the U.S. Court of Appeals for Veterans Claims, arguing that the Board failed to consider all potentially relevant issues, violating its statutory duty under 38 U.S.C. § 7104(d)(1).The Veterans Court affirmed the Board's decision, arguing that Thomas did not demonstrate the relevance of his service records to his 1971 claim. Thomas appealed to the United States Court of Appeals for the Federal Circuit, which found that the Veterans Court applied a more stringent legal standard than required under 38 U.S.C. § 7104. It ruled that the Board must consider all "potentially applicable" regulations raised in the record, not only those proven to be relevant or favorable by the veteran.The Federal Circuit court vacated the Veterans Court’s decision and remanded the case to the Board to provide an adequate written statement of its reasons for denying Thomas's claim for an earlier effective date for his PTSD, considering all relevant regulations and records. View "Thomas v. McDonough" on Justia Law

The case originates from the United States Court of Appeals for the Federal Circuit. The appellant, Herbie D. Vest, served on active duty in the United States Army from 1966 to 1971. In 1971, Vest filed a claim for service connection for hearing loss and tinnitus, which was granted at a 0% rating. A subsequent request for an increased rating was denied. In 1972, Vest sent a letter to the Veterans Administration Regional Office (RO) expressing his belief of an error in their decision. In 2016, Vest submitted a claim for compensation for Meniere's disease and "ears-ringing," which was granted at a 60% disability rating, which Vest disputed.In 2020, Vest argued that his 1972 letter constituted a Notice of Disagreement (NOD) and should be considered as such. However, the RO did not accept the letter as an NOD. The Board of Veterans’ Appeals found that the letter expressed dissatisfaction with the decision on his hearing loss disability, but did not express disagreement with the decision regarding tinnitus. The United States Court of Appeals for Veterans Claims dismissed Vest's appeal, holding that they did not have jurisdiction to address the question of defective notice. The court noted that Vest did not argue that he had submitted an NOD with the initial decision concerning tinnitus, and he didn't challenge the Board’s determinations that the letter was not an NOD for the tinnitus decision.The United States Court of Appeals for the Federal Circuit affirmed the dismissal of the appeal by the Veterans Court due to lack of jurisdiction. The court reasoned that the absence of an NOD on the 1971 tinnitus claim and the lack of any decision by the Board on that claim defeat jurisdiction in the Veterans Court. View "Vest v. McDonough" on Justia Law

This case involves Avue Technologies Corporation ("Avue") and the Secretary of Health and Human Services and the Administrator of the General Services Administration. Avue is a software development company that sells its software to private and government entities, which helps them automate administrative tasks while complying with statutory, regulatory, and policy requirements. Avue does not sell its software licenses directly to federal agencies. Instead, it sells annual subscriptions through third party Carahsoft Technology Corporation (“Carahsoft”), an authorized reseller that has a Federal Supply Schedule (“FSS”) contract with the General Services Administration (“GSA”).Avue tried to govern its relationship with end users of its software through an end-user licensing agreement ("EULA"), which is incorporated into the FSS contract between Carahsoft and the GSA. In 2015, the Food and Drug Administration ("FDA") placed a task order for a subscription to Avue's software under the FSS contract. However, in 2016, the FDA chose not to renew its subscription, leading Avue to claim that the FDA had violated its EULA.The Civilian Board of Contract Appeals ("Board") dismissed Avue's appeal for lack of jurisdiction, stating that even if the EULA established a contract between Avue and the U.S. Government, the Board lacked jurisdiction because the EULA was not a procurement contract within the meaning of the Contract Disputes Act ("CDA"). Avue appealed this decision to the United States Court of Appeals for the Federal Circuit.The court disagreed with the Board's decision, stating that Avue only needed to allege non-frivolously that it had a contract with the U.S. Government to establish the Board's jurisdiction, and it didn't need to prove the existence of such a contract. The court held that Avue's allegation that it was part of a procurement contract was non-frivolous and sufficient to establish the Board's jurisdiction. Therefore, the court vacated the Board's dismissal and remanded the case for further proceedings on the merits. View "AVUE TECHNOLOGIES CORPORATION v. HHS " on Justia Law

This case involves an appeal by Pfizer Inc. from decisions made by the U.S. Patent and Trademark Office Patent Trial and Appeal Board (the Board). The Board concluded that claims 1–45 of U.S. Patent 9,492,559, owned by Pfizer and related to immunogenic compositions comprising conjugated Streptococcus pneumoniae capsular saccharide antigens for use in pneumococcal vaccines, were unpatentable. The Board also denied Pfizer’s proposed amendments to the claims.Pfizer's first challenge pertained to the Board’s conclusion regarding the molecular weight of the glycoconjugate in the patent, arguing that the Board incorrectly applied the "result-effective variable doctrine." The court disagreed, upholding the Board's decision that the molecular weight was a result-effective variable that a person of ordinary skill in the art would have been motivated to optimize.Pfizer's second challenge related to the Board’s finding that the compositions of additional claims incorporating more specific glycoconjugates would have been obvious. The court disagreed with Pfizer's argument that without examples showing the claimed glycoconjugates would have each been immunogenic, there would have been no reasonable expectation of success.Thirdly, Pfizer challenged the Board’s denial of its motions to amend the claims. The court affirmed the Board's decision on some of the proposed claims but vacated the decision on others, remanding them for further consideration due to the Board’s lack of clarity.Lastly, Pfizer challenged the Patent and Trademark Office’s Director Review procedure, alleging it violated the Administrative Procedure Act (APA). The court rejected this argument, finding any potential APA violation was harmless as Pfizer had not demonstrated prejudice.Therefore, the court affirmed the Board’s decisions in part, vacated them in part, and remanded the case back to the Board for further proceedings. View "PFIZER INC. v. SANOFI PASTEUR INC. " on Justia Law

The case involved Sha’Lisa Lewis, a former correctional officer at the Federal Correctional Complex in Butner, North Carolina, who contested her termination from the Federal Bureau of Prisons (BOP) during her probationary period. Lewis contended that she did not receive notification of her termination until after her probationary term had ended. She argued that she was denied due process protections, such as a proposed removal action and a reasonable opportunity to respond.The United States Court of Appeals for the Federal Circuit examined the issue, focusing on the interpretation of 5 C.F.R. § 315.804, which mandates that an agency notify an employee in writing about the reasons for termination and the effective date. The court ruled that while the agency must notify the employee, the regulation does not necessitate the employee's actual receipt of the notice before the end of the probationary period. The court held that termination is effective if the agency does all that could be reasonably expected under the circumstances to deliver the notice before the end of the probationary period.In Lewis's case, the court concluded that BOP had made reasonable efforts to notify her of her termination before the end of her probationary period. Thus, the court affirmed that Lewis was effectively terminated as a probationary-period employee. View "LEWIS v. BOP " on Justia Law

Between 2010 and 2014, the United States Coast Guard convened Active Duty Enlisted Career Retention Screening Panels (CRSPs) to select enlisted service members for involuntary retirement. This process was carried out without following the procedures and standards of the then-applicable 14 U.S.C. § 357(a)–(h), which addressed involuntary retirement of certain Coast Guard service members with specified seniority. Several former Coast Guard service members, after being involuntarily retired through the CRSP process, brought a case against the United States in the Court of Federal Claims under the Tucker Act, asserting that their retirements were contrary to the law as the Coast Guard had not followed § 357(a)–(h). The government responded by invoking § 357(j), which stated that § 357(a)–(h) did not apply to a “reduction in force.” The issue of the applicability of that exception to the CRSPs was the primary topic of the appeal.The United States Court of Appeals for the Federal Circuit affirmed the Claims Court's decision that the involuntary retirements were unlawful because the CRSPs were not part of a “reduction in force.” The court concluded that a “reduction in force” as used in § 357(j) did not include actions to separate current occupants from their positions with the intent to refill those positions. The court rejected the government’s arguments for a different conclusion. Therefore, the court affirmed the Claims Court’s partial final judgment. View "TIPPINS v. US " on Justia Law

In this case, the United States Court of Appeals for the Federal Circuit reviewed a decision by the United States Court of Appeals for Veterans Claims (Veterans Court) that granted a petition for a writ of mandamus permitting the Board of Veterans' Appeals (Board) to hear appeals of adverse decisions rendered under the Program of Comprehensive Assistance for Family Caregivers (Caregiver Program). The claimants were Jeremy Beaudette, a Marine Corps veteran who was rated 100% disabled due to multiple concussions that resulted in traumatic brain injury and legal blindness, and his wife Maya Beaudette. They applied for benefits under the Caregiver Program in March 2013 and were found eligible. However, in February 2018, the Department of Veterans Affairs (VA) notified them that they were no longer eligible for Caregiver Program benefits. They appealed this decision through the VA Clinical Appeals process, but their appeals were denied. The Beaudettes then filed a petition for a writ of mandamus with the Veterans Court to permit Board review of adverse Caregiver Program decisions. In April 2021, a majority of a three-judge panel granted the Beaudettes' petition and certified the request for a class.The Veterans Court held that Congress mandated Board review of all Caregiver Program decisions, disagreeing with the VA's position that the phrase "medical determination" in § 1720G(c)(1) is a reference to a longstanding VA rule excluding medical determinations from Board review. The VA appealed this decision to the Federal Circuit. The Federal Circuit affirmed the Veterans Court's decision, holding that § 1720G(c)(1) of the Caregiver Act only bars judicial review of Caregiver Program decisions on the furnishing of assistance or support. The court concluded that the Beaudettes and other similarly situated veterans and caregivers have an indisputable right to judicial review of Caregiver Program decisions that do not affect the furnishing of support or assistance. View "BEAUDETTE v. MCDONOUGH " on Justia Law

In this case, the parents of W.J., a young man with a chromosomal abnormality and autism, brought a case under the National Childhood Vaccine Injury Act of 1986 against the Secretary of Health and Human Services, claiming that the Measles, Mumps, and Rubella vaccine administered to their son had caused or significantly aggravated his health issues. They filed their petition more than 15 years after the vaccine was administered, well beyond the Act's three-year statute of limitations. The parents argued that the statute of limitations should be equitably tolled due to their son's mental incapacitation, his minority status, and the government's alleged fraudulent concealment of a connection between the vaccine and autism.The United States Court of Appeals for the Federal Circuit affirmed the decision of the United States Court of Federal Claims, which had denied the parents' petition for review and confirmed a special master’s decision to dismiss the case as untimely. The court concluded that the mental incapacitation of the son did not qualify as an "extraordinary circumstance" warranting equitable tolling because the parents, as his legal guardians, had failed to demonstrate that they were unable to file a claim on his behalf. The court also rejected the arguments for minority tolling and fraudulent concealment, finding no basis for these in the Vaccine Act or its legislative history. The court further held that the special master had not erred in raising the issue of the statute of limitations, nor in dismissing the claim for failure to state a claim upon which relief could be granted. View "W. J. v. Health and Human Services" on Justia Law

The plaintiff, Great Northern Properties, L.P. ("GNP"), filed a lawsuit against the United States, alleging a Fifth Amendment taking of its coal leases on the Otter Creek property in Montana. GNP claimed that the federal government, through the Montana state regulatory authority, denied the necessary permits for coal mining. The United States Court of Appeals for the Federal Circuit affirmed the decision of the Court of Federal Claims, which dismissed the case for lack of subject matter jurisdiction. The court held that GNP could not establish that Montana's actions were coerced by the federal government or that Montana acted as an agent of the federal government. The court also noted that the federal government did not dictate the outcome in individual permitting cases and that state law governed the permitting process. Therefore, the federal government was not responsible for the permit denial, as Montana was not coerced to enact its own regulatory program following the passage of the Surface Mining Control and Reclamation Act. Furthermore, the court rejected GNP's claim that the existence of federal standards created an agency relationship between the federal government and Montana. View "GREAT NORTHERN PROPERTIES, L.P. v. US " on Justia Law

In 2020, the law firm Chestek PLLC applied for a trademark for the mark "CHESTEK LEGAL" but provided only a P.O. box as its domicile address. The United States Patent and Trademark Office (USPTO) refused the application because it did not comply with the domicile address requirement. Chestek argued that the rules enforcing this requirement were improperly promulgated under the Administrative Procedure Act (APA). The Trademark Trial and Appeal Board affirmed the examiner's refusal. On appeal to the United States Court of Appeals for the Federal Circuit, Chestek argued that the domicile address requirement was improperly promulgated for two reasons: the USPTO was required to comply with the requirements of notice-and-comment rulemaking under 5 U.S.C. § 553 but failed to do so because the proposed rule did not provide notice of the domicile address requirement adopted in the final rule, and the domicile address requirement is arbitrary and capricious because the final rule failed to offer a satisfactory explanation for the domicile address requirement and failed to consider important aspects of the problem it purports to address, such as privacy. The Federal Circuit found the domicile address requirement to be a procedural rule that is exempt from notice-and-comment rulemaking. Furthermore, the USPTO's decision to require the address provided by all applicants to be a domicile address was not arbitrary or capricious for failure to provide a reasoned justification. The court affirmed the Board's refusal to register Chestek's mark. View "In Re CHESTEK PLLC " on Justia Law